Evidence map›Paper›PMID 23129698›Full record

ArticleHypertension (Dallas, Tex. : 1979)2013

The β3 subunit contributes to vascular calcium channel upregulation and hypertension in angiotensin II-infused C57BL/6 mice.

Sujay V Kharade, Swapnil K Sonkusare, Anup K Srivastava, Keshari M Thakali, Terry W Fletcher, Sung W Rhee, Nancy J Rusch

Open access · bronzeAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Modulation of CaHandbook of experimental pharmacology · 2023
    Article
  4. Mechanisms of Vascular CaHandbook of experimental pharmacology · 2023
    Article
  5. Review
  6. Oxidative Regulation of Vascular CaAntioxidants (Basel, Switzerland) · 2022
    Review
  7. Novel Smooth Muscle CaCirculation · 2022
    Article
  8. Review
  9. Downregulation of CaFrontiers in pharmacology · 2022
    Article
  10. Review
  11. Cavβ3 Regulates CaDiabetes · 2021
    Article
  12. Article
  13. Review
  14. Review
  15. Calcium signals that determine vascular resistance.Wiley interdisciplinary reviews. Systems biology and medicine · 2019
    Review
  16. Article
  17. Dynamic L-type CaBiochimica et biophysica acta. Molecular cell research · 2018
    Article
  18. Blocking CaCell reports · 2018
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sujay V KharadeDepartment of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Swapnil K Sonkusare
Anup K Srivastava
Keshari M Thakali
Terry W Fletcher
Sung W Rhee
Nancy J Rusch
University of Arkansas for Medical Sciences · US

Funding

Vascular Calcium Channel Expression in HypertensionR01HL064806 · NHLBI · UNIV OF ARKANSAS FOR MED SCIS · PI RUSCH, NANCY J · 2000 to 2012
$3.4M
NHLBI NIH HHS R01 HL064806NHLBI NIH HHS R01 HL064806-12
6 · The paper itself

Abstract

Voltage-gated L-type Ca(2+) (Ca(v)1.2) channels in vascular smooth muscle cells are a predominant Ca(2+) influx pathway that mediates arterial tone. Channel biogenesis is accomplished when the pore-forming α(1C) subunit coassembles with regulatory Ca(v)β subunits intracellularly, and the multiprotein Ca(v)1.2 channel complex translocates to the plasma membrane to form functional Ca(2+) channels. We hypothesized that the main Ca(v)β isoform in vascular smooth muscle cells, Ca(v)β3, is required for the upregulation of arterial Ca(v)1.2 channels during the development of hypertension, an event associated with abnormal Ca(2+)-dependent tone. Ca(v)1.2 channel expression and function were compared between second-order mesenteric arteries of C57BL/6 wild-type (WT) and Ca(v)β3(-/-) mice infused with saline (control) or angiotensin II (Ang II) for 2 weeks to induce hypertension. The mesenteric arteries of Ang II-infused WT mice showed increased Ca(v)1.2 channel expression and accentuated Ca(2+)-mediated contractions compared with saline-infused WT mice. In contrast, Ca(v)1.2 channels failed to upregulate in mesenteric arteries of Ang II-infused Ca(v)β3(-/-) mice, and Ca(2+)-dependent reactivity was normal in these arteries. Basal systolic blood pressure was not significantly different between WT and Ca(v)β3(-/-) mice (98 ± 2 and 102 ± 3 mm Hg, respectively), but the Ca(v)β3(-/-) mice showed a blunted pressor response to Ang II infusion. Two weeks after the start of Ang II administration, the systolic blood pressure of Ca(v)β3(-/-) mice averaged 149 ± 4 mm Hg compared with 180 ± 5 mm Hg in WT mice. Thus, the Ca(v)β3 subunit is a critical regulatory protein required to upregulate arterial Ca(v)1.2 channels and fully develop Ang II-dependent hypertension in C57BL/6 mice.

Indexed as

Angiotensin IIAnimalsBlood PressureCalciumCalcium Channels, L-TypeHypertensionMesenteric ArteriesMiceMice, Inbred C57BLMuscle ContractionMuscle, Smooth, VascularMyocytes, Smooth MuscleUp-RegulationAngiotensin IICalciumCalcium Channels, L-TypeL-type calcium channel alpha(1C)

Identifiers

PMID23129698
PMCPMC3748590
OpenAlexW2105966328

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.